Graham Capital Management, L.P. Theravance Biopharma, Inc. Transaction History
Graham Capital Management, L.P.
- $4.38 Billion
- Q1 2025
A detailed history of Graham Capital Management, L.P. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 24,954 shares of TBPH stock, worth $268,255. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,954
Previous 36,364
31.38%
Holding current value
$268,255
Previous $342,000
35.09%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding TBPH
# of Institutions
136Shares Held
47.3MCall Options Held
700Put Options Held
1.4K-
Madison Avenue Partners, LP New York, NY9.51MShares$102 Million10.97% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$80.2 Million1.9% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$51.1 Million8.37% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$40.6 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$29.7 Million3.74% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $718M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...